New Frontiers In Immunotherapy For Cancer Treatment

Abstract

Cancer immunotherapy has revolutionized oncology by leveraging the immune system's ability to target and eliminate cancer cells. This review explores the latest advancements in immunotherapy, including immune checkpoint inhibitors, CAR-T cell therapy, bispecific antibodies, oncolytic viruses, and cancer vaccines. It also highlights the emerging role of natural killer (NK) cell therapy and discusses strategies to overcome challenges such as tumor heterogeneity, immunosuppressive microenvironments, and therapy-related toxicities. Additionally, the review emphasizes future directions in combination therapies, biomarker discovery, gene editing, and cost-effective solutions to improve accessibility. These innovations hold the potential to redefine cancer care, offering hope for improved survival and quality of life for patients worldwide.